Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
2022 · Nature · 129 citations
https://doi.org/10.1038/s41586-022-04833-8
M
Manoj Chelvanambi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
1.9K
Citations
15
h-index
16
i10-index
Manoj Chelvanambi is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Genetic factors in colorectal cancer & Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research. The author has an h-index of 15, co-authored 108 publications.
ORCID: 0000-0003-2130-3118Papers by this author
worksGut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
2023 · JAMA Dermatology · 22 citations
https://doi.org/10.1001/jamadermatol.2023.2955
PPP2R1A mutations portend improved survival after cancer immunotherapy
2025 · Nature · 20 citations
https://doi.org/10.1038/s41586-025-09203-8
Single-cell spatial transcriptomics delineates the presence and function of intratumoral bacterial signals in acral melanoma patients treated with immunotherapy
2025 · EJC Skin Cancer · 0 citations
https://doi.org/10.1016/j.ejcskn.2025.100518
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat